biomedicina slovenica


renin-angiotensin : 60

  1. Makuc Jana; Šeruga Maja; Završnik Matej; Cilenšek Ines; Petrovič Danijel
    Angiotensinogen (AGT) gene missense polymorphisms (rs699 and rs4762) and diabetic nephropathy in Caucasians with type 2 diabetes mellitus
    2017
  2. Šeruga Maja; Makuc Jana; Završnik Matej; Cilenšek Ines; Ekart Robert; Petrovič Danijel
    Polymorphism of angiotensin-converting enzyme (rs4340) and diabetic nephropathy in Caucasians with type 2 diabetes mellitus
    2016
  3. Pal Marjetka; Ferk Polonca; Leskošek Branimir
    Ambulantno predpisovanje antihipetenzivov in kakovost nadzora arterijske hipertenzije v Sloveniji
    [Outpatient prescribing of antihypertensives and quality of arterial hypertension control in Slovenia]
    2014
  4. Janić Miodrag; Lunder Mojca; Šabovič Mišo
    #A #new anti-ageing strategy focused on prevention of arterial ageing in the middle-aged population
    2013
  5. Trošt Rupnik Alijana; Pajek Jernej; Guček Andrej; Osredkar Joško; Kovač Damjan; Bren Andrej; Klančič Dimitrij; Saksida Silvana; Rus Igor; Globokar Mateja; Drozg Andrej; Lešnik Marjeta; Plešivčnik Zala; Ekart Robert; Kralj Lopert Simona; Lindič Jelka
    Influence of renin-angiotensin-aldosterone system-blocking drugs on peritoneal membrane in peritoneal dialysis patients
    2013
  6. Bevc Sebastjan
    Aldosteron, zaviralci aldosteronskih receptorjev in kronična ledvična bolezen
    [Aldosterone, aldosterone receptor blockers and chronic kidney disease]
    2011
  7. Janić Miodrag; Lunder Mojca; Šabović Mišo
    Okrnjeno delovanje endotelija
    [Endothelial dysfunction]
    2011
  8. Štimac Danijela; Polić-Vižintin Marina; Škes Marija; Cattunar Albert; Cerović Robert; Stojanović Dražen
    Utilization of cardiovascular drugs in Zagreb 2001-2005
    2010
  9. Pal Marjetka; Leskošek Brane L; Ferk Polonca
    Poraba antihipertenzivnih zdravil v Sloveniji in primerjava z Norveško
    [Consumption of antihypertensives in Slovenia and comparison with Norway]
    2011
  10. Bajuk-Studen Katica; Šebeštjen Miran; Pfeifer Marija; Preželj Janez
    Influence of spironolactone treatment on endothelial function in non-obese women with polycystic ovary syndrome
    2011
  11. Stoka Veronika; Turk Vito
    A structural approach to understand the cross-talk of the kallikrein-kinin and the renin-angiotensin systems
    2010
  12. Hojs Radovan
    Zavora renin-angiotenzin-aldosteronskega sistema (RAAS) - več kot le zdravljenje hipertenzije?
    [Renin angiotensin aldosterone system (RAAS) blockade - more than antihypertensive treatment?]
    2010
  13. Pongrac-Barlovič Draženka; Cooper Mark E
    Diabetes: RAS inhibition: probably not a one-size-fits-all approach
    2009
  14. Pongrac-Barlovič Draženka; Thomas Merlin C; Jandeleit-Dahm Karin
    Cardiovascular disease: what's all the AGE/RAGE about?
    2010
  15. Šušteršič Miha; Bunc Matjaž
    Nova spoznanja o reninsko-angiotenzinskemu sistemu s poudarkom na (pro)reninu in (pro)reninskem receptorju ter možnostih njune zavore
    [New knowledge of renin-anginotensin-aldosterone system with emphasis on (pro)renin, (pro)renin receptor and possibilities of their blockade]
    2009
  16. Magdič Jožef
    Pleotropni učinki zdravil v preventivi možganskožilnih bolezni
    [Pleiotrophic effects of drugs used for stroke prevention]
    2009
  17. Azarija Jelena; Peternel Polona
    Ambulantno zdravljenje venske tromboze
    [Outpatient tratment of venous thrombosis]
    2009
  18. Bajuk-Studen Katica; Preželj Janez; Kocjan Tomaž; Pfeifer Marija
    Mehanizmi srčno-žilne orgroženosti žensk s sindormom policističnih ovarijev
    [Mechanisms of cardiovascular disease risks in women with polycystic ovary syndrome]
    2009
  19. Šušteršič Miha; Bunc Matjaž
    Nova spoznanja o reninsko-angiotenzisko-aldosteronskem sistemu in nove strategije njegove zavore
    [New knowledge of renin-angiotensin-aldosterone system and new strategies of its blockade]
    2008
  20. Bombek Mirko
    Od hipertenzije do srčnega popuščanja - pomen dvojne zavore renin-angiotenzinskega sistema
    2008
  21. Kogoj Polonca; Hawlina Simin; Bunc Matjaž
    Od endotelija odvisno uravnavanje žilnega napona
    2008
  22. Petrovič Daniel
    Optimizing cardiac and vascular protection in hypertensive patients with type 2 diabetes
    2008
  23. Osredkar Joško
    Priporočila za uporabo biokemijskih označevalcev pri srčnem popuščanju
    [Recommendations on the use of biochemical markers in heart failure]
    2007
  24. Petek-Šter Marija; Švab Igor
    Nadzor krvnega tlaka pri bolnikih z arterijsko hipertenzijo v Sloveniji
    [Blood pressure control in patients with arterial hypertension in Slovenia]
    2007
  25. Šabovič Mišo
    Pomen zaviralcev angiotenzinske konvertaze pri zdravljenju ishemične bolezni srca
    [The role of ACE inhibitors in the treatment of coronary artery disease]
    2007
  26. Žemva Aleš; Benca Maja
    From endothelial dysfunction to hypertension
    [Od endotelijske disfunkcije do hipertenzije]
    2006
  27. Gužič-Salobir Barbara
    Pomen renin-angiotenzinskega sistema pri bolnikih s srčnim popuščanjem
    [The meaning of renin-angiotensin system with patients who have heart failure]
    2006
  28. Terzić Rifet; Letonja Mitja; Terzić Ibrahim; Šehić Amela; Merić Muharem; Teran Nataša
    Insertion/deletion polymorphism of angiotensin-converting enzyme gene - risk factor for coronary artery disease in the Tuzla region population (Bosnia and Herzegovina)
    [Insercijski/delecijski polimorfizam u genu angiotenzin konvertirajučeg enzima (ACE) - čimbenik rizika bolesti koronarnih arterija u stanovništvu Tuzlanske regije (Bosna i Herzegovina)]
    2003
  29. Vrtačnik-Bokal Eva; Meden-Vrtovec Helena; Verdenik Ivan
    Uterine arterial blood flow and the substances of ovarian rennin-angiotensin system in women with polycystic ovaries undergoing in vitro fertilization
    2006
  30. Vrtačnik-Bokal E; Verdenik I
    Uterine arterial blood flow and the substances of ovarian renin-angiotensin system in PCOS
    2005
  31. Accetto Rok
    Esencialna arterijska hipertenzija
    2004
  32. Gregorič A; Marčun-Varda N
    Načela zdravljenja hipertenzije pri otrocih
    [Principles of treatment in childhood hypertension]
    2004
  33. Šabovič Mišo
    Novi podatki o vplivu ACE-inhibitorjev na upočasnitev ateroskleroze
    [New data on the effect of ACE inhibitors on retarding atherosclerosis]
    2004
  34. Petrovič Danijel; Peterlin Borut
    Pharmacogenomic considerations of the insertion/deletion gene polymorphism of the angiotensin I-converting enzyme and coronary artery disease
    2004
  35. Hafner Matjaž
    Ascites - priporočila za zdravljenje
    [Ascites - guidelines for treatment]
    2002
  36. Vrtačnik-Bokal E
    Patofiziologija nastnaka sindroma hiperstimulacije jajčnikov
    2002
  37. Petrovič Danijel; Bidovec Matjaž; Peterlin Borut
    Gene polymorphisms of the renin-angiotensin-aldosterone system and essential arterial hypertension in childhood
    2002
  38. Sket Dušan; Ribarič Samo
    Ledvice, zgradba in funkcija nefrona, nastajanje in sestava seča
    2002
  39. Sketelj Janez
    Primarna arterijska hipertenzija
    2001
  40. Bidovec M; Petrovič D; Peterlin B; Zorc M; Kenda R
    Polymorphism of the renin-angiotensin system and natriuretic factor in children with hypertension
    2001
  41. Petrovič Danijel; Zorc Marjeta; Kanič Vojko; Peterlin Borut
    Interaction between gene polymorphisms of renin-angiotensin system and metabolic risk factors in premature myocardial infarction
    2001
  42. Bidovec Matjaž
    Povezava med polimorfizmom gena za angiotenzinsko konvertazo, za angiotenzinogen in za atrijski natriuretični faktor ter esencialno arterijsko hipertenzijo pri mladostnikih
    2001
  43. Vrtačnik-Bokal E; Meden-Vrtovec H
    Policistični ovariji, renin-angiotenzinski sistem in zrelost oocitov
    2000
  44. Vrtačnik-Bokal Eda
    Vazoaktivne snovi in arterijski pretok v maternici po vzpodbujanju jajčnikov z gonadotropini
    [Vasoactive substances and uterine arterial blood flow after gonadotrophin ovarian stimulation]
    2000
  45. Hojs Radovan
    Antagonsti receptorjev za angiotenzin II in ledvice
    [Angiotensin II receptor antagonists and the kidneys]
    2000
  46. Lavrenčič Aleša
    Irbesartan za zdravljenje arterijske hipertenzije
    [Irbesartan in the treatment of arterial hypertension]
    2000
  47. Petrovič Danijel
    Molekularnogenetska analiza družinske hiperholesterolemije in koronarne bolezni
    [Molecular genetic analysis of familial hypercholesterolemia and coronary artery disease]
    1999
  48. Petrovič D; Zorc M; Keber I; Peterlin B
    The role of genetic polymorphisms of the renin-angiotensin system in premature coronary artery disease
    1998
  49. Cleutjens Jack PM
    The role of apoptosis in myocardial infarction
    1998
  50. Žemva Aleš
    Treatment of congestive heart failure with angiotensin-converting enzyme (ACE) inhibitors
    1998
  51. Petrovič Danijel; Peterlin Borut
    Genetic polymorphism and coronary artery disease
    1998
  52. Peterlin Borut; Petrovič Danijel; Milanez Tomaž
    Pomen nekaterih genetskih polimorfizmov za razvoj ateroskleroze
    [The role of the genetic polymorphisms in the process of atherosclerosis]
    1998
  53. Accetto Rok; Dobovišek Jurij
    Blokatorji angiotenzinskih receptorjev
    1997
  54. Rutar A; Pečar S
    Biosinteza angiotenzina II in njegovi receptorji kot mesto delovanja sodobnih hipotenzivnih učinkovin
    [Biosynthesis of the angiotensin II and angiotensin II receptors as a target for modern hypotensive active compounds]
    1995
  55. Kajtna-Koselj M
    Arterijska hipertenzija po presaditvi ledvic
    1992
  56. Kveder R
    Krvni tlak pri bolnikih na kronični dializi
    1992
  57. Mihelič-Brčič M
    Renoparenhimska hipertenzija
    1992
  58. Žemva A
    Zaviralci angiotenzinske konvertaze
    [Angiotensin converting enzyme inhibitors]
    1989
  59. Sabljar-Matovinović M; Škegro D; Čerlek S
    Reaktivnost reninskog-angiotenzinskog sustava u bolesnika s cirozom jetre i ascitesom
    1988
  60. Est M
    Delovanje in medsebojno delovanje antihipertonikov
    1987


Nova poizvedba      Pripombe      Na vrh strani                        Inštitut za biostatistiko in medicinsko informatiko